Plainfield, IN, United States of America

Michael P Conway

This inventor holds 10 USPTO granted patents and 2 published patent applications. Top assignees: Dekalb Genetics Corporation, Monsanto Technology LLC, Other. Active years: 1999-2021.

USPTO Granted Patents = 10 

% Patents Active = 90.0

Average Co-Inventor Count = 1.1

ph-index = 4

Forward Citations = 32(Granted Patents)


Location History:

  • Plainfield, IN (US) (1999 - 2002)
  • Indianapolis, IN (US) (2003 - 2004)
  • Medford, MA (US) (2021)

Company Filing History:


Years Active: 1999-2021

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Journey of Michael P Conway

Introduction:

Michael P Conway, a distinguished inventor hailing from Plainfield, IN (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents:

Michael P Conway's latest patents include a revolutionary software application for enhancing cybersecurity measures in financial institutions and a cutting-edge medical device designed to improve patient outcomes in surgical procedures.

Career Highlights:

With a career spanning over two decades, Michael P Conway has established himself as a visionary in the tech industry. His innovative solutions have garnered widespread acclaim and have been instrumental in shaping the future of various sectors.

Collaborations:

Throughout his career, Michael P Conway has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly with diverse teams has been a key factor in the success of his projects.

Conclusion:

In conclusion, Michael P Conway's relentless pursuit of innovation and his passion for creating solutions to complex problems have solidified his reputation as a trailblazer in the world of technology. His contributions continue to inspire future generations of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…